News
Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS. The ...
The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...
Breakthrough Alzheimer’s drugs rejected for use on the NHS. Here’s how they work - Scientists and doctors remain divided on ...
THE NHS is failing to keep up with science, experts blasted after breakthrough new dementia drugs were rejected again by the ...
WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and ...
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
A 56-year-old man attended a sexual health clinic for asymptomatic rectal Chlamydia trachomatis treatment. Patient history ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.
Brain scientists have made a breakthrough that could help diagnose Parkinson's disease and Multiple System Atrophy much ...
Nearly 11 years after Theresa Benn's body was discovered in Choccolocco Creek, investigators have returned to a rural stretch ...
Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results